Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

NCT05366751 is registered in ClinicalTrials.gov with Sage Therapeutics as lead sponsor.

NCT NCT05366751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
Lead sponsor
Sage Therapeutics
Phase
Phase 2/3
Overall status
Terminated
Start date
June 3, 2022
Completion date
September 10, 2024
Enrollment
97 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor